Published on 25/11/2025

KRIs, KPIs and QC Checks to Monitor Lay Summaries & Plain-Language Results Quality

In the realm of clinical research, ensuring the accessibility and clarity of research results is paramount. Lay summaries and plain-language results serve as vital tools for communicating complex clinical data to non-specialist audiences. This tutorial provides a comprehensive step-by-step guide focused on developing Key Risk Indicators (KRIs), Key Performance Indicators (KPIs), and implementing Quality Control (QC) checks to ensure the quality of these documents. The target audience includes clinical operations, regulatory affairs, and medical affairs professionals involved in clinical trials, particularly those overseeing principal investigator clinical trial activities.

Understanding Lay Summaries and Plain-Language Results

Lay summaries and plain-language results articulate the findings of clinical trials in comprehensible formats. These documents aim to bridge the communication gap between researchers and the general public, patients, and stakeholders. They are not only essential for ethical considerations, such as patient engagement and transparency, but they are also increasingly required by regulatory bodies across the US, UK, and EU.

To effectively monitor the quality of lay summaries, it is crucial to establish a structured approach that includes KRIs and KPIs. This ensures that the documents meet the necessary standards for clarity, relevance, and accuracy.

Components of Lay Summaries

Lay summaries should include several critical components:

• Study Objectives: Clearly articulate what the study aims to achieve.
• Methodology: Describe the research design and procedures in a non-technical manner.
• Results: Provide a summary of the significant findings.
• Conclusions: Highlight the implications of the findings for patients and the wider community.
• Next Steps: Mention future research directions or applications of the findings.

Establishing Key Risk Indicators (KRIs)

KRIs serve as early warning signs that may indicate potential issues affecting the quality of lay summaries and plain-language results. By systematically identifying and monitoring these indicators, clinical research teams can proactively address risks before they impact document quality.

Step 1: Identify Potential Risks

Start by conducting a risk assessment to identify various potential concerns that could jeopardize the quality of lay summaries. Common risks may include:

• Inaccurate or misleading information.
• Inadequate translation or cultural adaptation for target audiences.
• Failure to engage stakeholders during the drafting process.

Step 2: Define KRIs for Each Identified Risk

Once risks have been identified, it is crucial to define specific KRIs that reflect these risks. For instance:

• Proportion of Misleading Claims: Percentage of lay summaries flagged for inaccuracy by the review committee.
• Stakeholder Engagement Rate: Percentage of stakeholders who provide feedback during the draft phase.
• Translation Accuracy Rate: Percentage of translations that meet professional standards.

Step 3: Regular Monitoring of KRIs

Implement a schedule for monitoring KRIs, such as quarterly or biannual evaluations. Document the findings and actions taken in response to any highlighted issues.

Establishing Key Performance Indicators (KPIs)

KPIs are measurable values that assess the success of various processes in creating lay summaries and plain-language results. A focus on KPIs allows for the quantification of the effectiveness and efficiency of the process.

Step 1: Define Critical Performance Areas

KPIs should be developed around critical performance areas associated with the creation of lay summaries. These areas might include:

• Timeliness of document completion.
• Clarity and readability of the text.
• Stakeholder satisfaction with the final documents.

Step 2: Create Specific KPIs

Each performance area must have specific, measurable KPIs. Examples include:

• Document Turnaround Time: Average number of days taken from draft to final version.
• Readability Score: Assessed using tools like the Flesch-Kincaid scale.
• Stakeholder Satisfaction Survey Results: Average satisfaction rating based on surveys.

Step 3: Analyze KPI Data Regularly

Compile data on KPIs and analyze trends over time. Establish performance targets and adjust workflows or procedures based on this feedback to promote continuous improvement.

Implementing Quality Control Checks

Quality Control (QC) checks are essential to ensure that lay summaries and plain-language results meet predefined standards. Implementing QC can greatly enhance the reliability and validity of the produced documents.

Step 1: Develop QC Checklists

A well-structured QC checklist should address all critical aspects of lay summaries, including content accuracy, clarity, and alignment with regulatory requirements. Ensure that the checklist is comprehensive and tailored to the target audience’s needs.

Step 2: Conduct Independent Reviews

Establish a routine of independent peer reviews, where team members not involved in the drafting process assess the documents. This practice promotes objectivity and introduces fresh insights into the narrative quality. Utilize review criteria established in the QC checklist as guidance.

Step 3: Implement Feedback Loops

After reviews, facilitate discussions about feedback. Ensure that constructively critiqued points are addressed promptly, and refine the summaries based on reviewer input. Developing a system for incorporating feedback can enhance document quality significantly.

Integrating KRIs, KPIs, and QC into Clinical Trial Platforms

As clinical trials increasingly utilize digital clinical trial platforms, integrating KRIs, KPIs, and QC checks into these systems can enhance efficiency and data management.

Step 1: Utilize Clinical Trial Management Systems (CTMS)

Employ state-of-the-art CTMS to monitor KRIs and KPIs in real time. These platforms can automate data collection and reporting, making it easier for teams to assess performance and identify trends.

Step 2: Ensure Data Accuracy and Consistency

Implement data checks within the CTMS to maintain high-quality data integrity. This includes verification processes for all electronic documents, particularly when generating lay summaries from raw clinical data.

Step 3: Train Team Members on Platform Features

Regular training and updates regarding platform functionalities and features will ensure that all team members use the clinical trial platform effectively, leading to better data handling and improved overall project outcomes.

Conclusion

Monitoring lay summaries and plain-language results quality through KRIs, KPIs, and QC checks is paramount in the context of clinical trials. This structured approach allows clinical operations, regulatory affairs, and medical affairs professionals to ensure that essential findings are communicated effectively, thereby improving patient engagement and transparency in clinical research.

Incorporating these methodologies not only elevates the quality of medical documentation but also enforces compliance with regulatory guidelines issued by bodies such as the FDA and EMA, fostering trust among stakeholders and enhancing study credibility. By applying this tutorial, organizations can enhance their clinical trial documentation processes and ultimately contribute to better health outcomes.